末梢液体塞栓薬の世界市場：市場規模・予測、世界・地域別シェア、動向、成長機会分析 - タイプ別、用途別、地域別

世界の末梢液体塞栓薬の市場規模は、2023年に4,042万米ドルに達し、2023～2031年にかけてCAGR 9.1%で成長し、2031年には8,141万米ドルに達すると予測されています。

末梢液体塞栓薬は、インターベンショナルラジオロジー手技において、漏出血管や奇形を塞ぐために使用される物質です。これらの薬剤は、注入後に固化して栓を形成し、標的部位への血流を遮断します。

温度誘起相変化システムとpHトリガー塞栓薬の市場開拓が市場成長の動向として作用しています。

液体塞栓は、生体工学、特に末梢処置において大きな関心を集めています。液体塞栓薬は、コイルやカテーテルが到達できない末梢部、病巣部、あるいは遠位部に浸透することができます。現在使用されている液体塞栓薬は、ほとんどの臨床ニーズを満たすことができるが、いくつかの欠点があります。そのため、画像特性の改善、合併症の軽減、流路性能の最適化、薬物負荷の実現などを目的として、さまざまな新規液体塞栓薬が開発されています。低侵襲イメージング手技の分野で臨床的に調整された塞栓薬を開発するためには、関連する副作用（毒性、接着性など）、生体機能性（生体適合性、生分解性、生体力学、生理活性）、放射線透過性など、さらに重要な材料特性を系統的に調査することが不可欠です。

温度感受性ポリマー溶液は、体内では室温でゾル注入可能な状態からゲル状態に変化します。ポリ（N-イソプロピルアクリルアミド）（PNIPAAm）は32℃の下限臨界溶液温度（LCST）に反応して可逆的な相転移を示します。2015年にQianらによってJournal of Controlled Releaseに発表された研究によると、肝がんのTACE用のイオヘキソール分散液を用いたポリ（N-イソプロピルアクリルアミド-co-ブチルメチルアクリレート）ゲルは、ウサギにおける腎動脈の効果的な塞栓とドキソルビシンの徐放性を示しました。同様に、2011年にWangらによってNational Library of Medicineに発表された研究によると、キトサン/B-グリセロリン酸（C/GP）はウサギの腎動脈閉鎖に成功し、塞栓薬としての可能性を示しました。同様に、2011年にWiley Online Libraryに掲載された研究によると、Zhaoらも塞栓のための温度感受性PNIPAAm-iohexolナノゲルを調査しています。相転移温度（36.5℃）以上の疎水性相互作用により、in situ血管鋳造用の階層的な3Dゲルネットワークが形成されました。末梢塞栓薬であるリピオドールと比較して、ナノゲルはウサギのVX2肝腫瘍においてより優れた末梢塞栓効果を示しました。

さらに、ポロキサマー407（ポリエチレンオキシドa-ポリプロピレンオキシドb-ポリエチレンオキシドaのトリブロックコポリマー）を含む感温性液体塞栓ハイドロゲルが肝臓がん治療のために提案されています。このポロキサマー407、ヒドロキシメチルセルロース、アルギン酸ナトリウム、ヨウジキサノールからなる複合ハイドロゲル（PSHI）は、温度の上昇とともに流動ゾルと収縮ゲルの2相を示しました。特に、PSHI-Ca2+を用いたVX2肝がんモデルでは、塞栓後に腫瘍が消失し、完全な閉塞が証明されました。

pH感受性の有効成分は、in vitro環境と生理的環境との間のpH変化により相転移を起こします。これらのハイドロゲルはpHに反応して膨潤したり崩壊したりするが、これは薬物放出の制御に用いられます。

Nguyenらが2016年にRoyal Society of Chemistryに発表した研究によると、肝細胞がんのTACE用に、ポリ（ホオ-カプロラクトン-コ-ラクチド）（PCLA）、PEG、ポリ（ウレタンスルフィドスルファメタジン）（PUSSM）からなる共重合体、PCLA-PUSSMが開発されました。この生分解性材料はドキソルビシンを担持し、pHの低下に反応して相転移を示しました。このハイドロゲルはドキソルビシンの徐放性を示しながら、VX2ウサギ腫瘍モデルの肝腫瘍の塞栓に成功しました。ラットモデルでは、塞栓により腫瘍への血液供給が停止し、低酸素による酸性環境が形成され、乳酸アシドーシスが誘発されました。低いpHが薬物放出を誘発し、in vivoでの腫瘍の成長を抑制することに成功しました。

温度感受性およびpHトリガーで試験中の液体塞栓薬のいくつかを以下に示します。：

• 表1.温度感受性およびpHトリガーゲル化試験中の液体塞栓薬

液体塞栓薬メカニズムの利点、古典的使用シナリオまたは試験条件

キトサン／B-グリセロリン酸（キトサン／B-GP）温度およびpHトリガーゲル化ドラッグデリバリーウサギの腎動脈

温度トリガーゲル化ドラッグデリバリーウサギのVX2原発性肝腫瘍

ポリ（N-イソプロピルアクリルアミド-コ-ブチルメチルアクリレート）ナノゲル（PIBナノゲル）温度トリガーゲル化リピオドールよりも優れた塞栓効果ウサギのVX2肝腫瘍原発巣

ポロキサマー407温度誘起ゲル化一時的な血管閉塞イヌの腎動脈

ポロキサマー407,アルギン酸ナトリウム,ヒドロキシメチルセルロース,ヨウジキサノール,カルシウムイオン（PSHI-Ca2+）温度誘起ゲル化放射線透過性ウサギの原発性VX2肝腫瘍

スルファメタジンベースのハイドロゲルpHトリガーゲル化ドラッグデリバリーウサギのVX2肝腫瘍原発巣

ポリ（アミノエステルウレタン）ブロックポリマー（PEAU）温度およびpHトリガーゲル化ドラッグデリバリーウサギにおけるVX2肝腫瘍の原発巣

このように、温度誘起相変化システムとpHトリガー塞栓薬への注目と発展は、今後数年間、末梢液体塞栓薬市場に新たな動向をもたらすと予想されます。

末梢液体塞栓薬の市場分析は、タイプ、用途、地域の各セグメントを考慮して行われました。タイプ別では、末梢液体塞栓薬市場は重合性液体塞栓薬と沈殿性液体塞栓薬に二分されます。用途別では、末梢液体塞栓薬市場はエンドリークII型、奇形、出血・外傷、静脈瘤、腫瘍、内臓動脈瘤に分類されます。

末梢液体塞栓薬市場調査範囲は、北米（米国、カナダ、メキシコ）、欧州（スペイン、英国、ドイツ、フランス、イタリア、その他の欧州）、アジア太平洋（韓国、中国、日本、インド、オーストラリア、その他のアジア太平洋）、中東＆アフリカ（南アフリカ、サウジアラビア、アラブ首長国連邦、その他の中東・アフリカ）、中南米（ブラジル、アルゼンチン、その他の中南米）です。北米は世界の末梢液体塞栓薬市場に最も貢献しています。アジア太平洋は、2023～2031年の間に市場で最も高いCAGRを示すと予測されています。

北米地域の市場成長は、同地域全体で動脈瘤、外傷、その他の症例が増加していることに起因しています。カナダ市場は、末梢障害に関する懸念の高まりに対処するための政府支援の高まりから成長が見込まれています。メキシコの市場は、製薬産業と医療ツーリズムの成長により成長すると推定されます。アジア太平洋の末梢液体塞栓薬市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋に区分されます。アジア太平洋の市場成長は、末梢動脈疾患（PAD）の有病率の上昇、低侵襲手術の需要の増加、病院や外来手術センターの数の増加、市場プレイヤーによる新興国への注目の高まり、アジア太平洋のヘルスケアインフラの発展など、さまざまな要因によってもたらされます。

米国疾病管理予防センター（CDC）、欧州医薬品庁（EMA）、汎米保健機構（PAHO）、世界保健機関（WHO）は、末梢液体塞栓薬市場に関する報告書を作成する際に参照した一次情報および二次情報の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

• 主要な洞察

第3章 調査手法

• 2次調査
• 1次調査
  • 仮説の策定
  • マクロ経済要因分析
  • 基礎数値の作成
  • データの三角測量
  • 国レベルのデータ

第4章 末梢液体塞栓薬の市場情勢

• PEST分析
• 地域別価格分析、2023年

第5章 末梢液体塞栓薬市場 - 主要市場力学

• 末梢液体塞栓薬市場 - 主な市場力学
• 市場促進要因
  • 末梢血管疾患の発生率の増加
  • 低侵襲手技に対する需要の増加
• 市場抑制要因
  • 塞栓薬の高コスト
• 市場機会
  • 市場プレイヤーによる戦略的イニシアチブの高まり
• 今後の動向
  • 温度誘起相変化システムとpHトリガー塞栓薬の開発
• 影響分析

第6章 末梢液体塞栓薬市場：世界市場分析

• 末梢液体塞栓薬市場の売上高、2021～2031年
• 末梢液体塞栓薬の市場分析
• 市況分析、2023年

第7章 末梢液体塞栓薬の市場分析：タイプ別

• 重合性液体塞栓薬
• 沈殿型液体塞栓薬

第8章 末梢液体塞栓薬の市場分析：用途別

• エンドリークII型
• 奇形
• 出血および外傷
• 静脈瘤
• 腫瘍
• 内臓動脈瘤

第9章 末梢液体塞栓薬市場：地域別分析

• 北米
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • その他の中東・アフリカ
• 中南米
  • ブラジル
  • アルゼンチン
  • その他の中南米

第10章 産業情勢

• 末梢液体塞栓薬市場における成長戦略
• 無機的成長戦略
• 有機的成長戦略

第11章 企業プロファイル

• Medtronic Plc
• B Braun SE
• Guerbet SA
• Sirtex Medical Ltd
• Balt
• MicroVention Inc
• Johnson & Johnson
• GEM srl

第12章 付録

List Of Tables

• Table 1. Peripheral Liquid Embolic Agents Market Segmentation
• Table 2. Regional Pricing Analysis, Price (US$)/ML, 2023
• Table 3. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation
• Table 4. Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 5. Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 6. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 7. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
• Table 8. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 9. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
• Table 10. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 11. North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
• Table 12. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 13. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 14. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 15. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 16. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 17. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 18. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 19. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 20. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 21. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 22. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
• Table 23. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 24. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
• Table 25. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 26. Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
• Table 27. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 28. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 29. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 30. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 31. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 32. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 33. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 34. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 35. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 36. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 37. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 38. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 39. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 40. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 41. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 42. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 43. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 44. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 45. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 46. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 47. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 48. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 49. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 50. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 51. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 52. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 53. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
• Table 54. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 55. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
• Table 56. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 57. Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
• Table 58. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 59. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 60. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 61. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 62. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 63. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 64. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 65. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 66. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 67. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 68. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 69. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 70. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 71. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 72. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 73. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 74. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 75. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 76. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 77. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 78. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 79. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 80. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 81. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 82. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 83. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 84. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
• Table 85. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 86. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
• Table 87. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 88. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
• Table 89. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 90. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 91. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 92. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 93. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 94. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 95. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 96. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 97. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 98. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 99. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 100. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 101. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 102. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 103. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 104. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 105. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 106. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 107. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Type
• Table 108. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 109. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Polymerizing Liquid Embolic Agent
• Table 110. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 111. South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast to 2031(ML) - by Precipitating Liquid Embolic Agent
• Table 112. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 113. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 114. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 115. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 116. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 117. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 118. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 119. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 120. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 121. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
• Table 122. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Polymerizing Liquid Embolic Agent
• Table 123. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Precipitating Liquid Embolic Agent
• Table 124. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand) - by Application
• Table 125. Recent Inorganic Growth Strategies in the Peripheral Liquid Embolic Agents Market
• Table 126. Recent Organic Growth Strategies in the Peripheral Liquid Embolic Agents Market
• Table 127. Glossary of Terms, Peripheral Liquid Embolic Agents Market

List Of Figures

• Figure 1. Peripheral Liquid Embolic Agents Market Segmentation, by Geography
• Figure 2. PEST Analysis
• Figure 3. Impact Analysis of Drivers and Restraints
• Figure 4. Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021-2031
• Figure 5. Manufacturers Market Positioning, 2023
• Figure 6. Peripheral Liquid Embolic Agents Market Share (%) - by Type (2023 and 2031)
• Figure 7. Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• Figure 8. Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• Figure 9. Peripheral Liquid Embolic Agents Market Share (%) - by Application (2023 and 2031)
• Figure 10. Endoleak Type II: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• Figure 11. Malformations: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• Figure 12. Bleedings and Trauma: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• Figure 13. Varicose Vein: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• Figure 14. Tumours: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• Figure 15. Visceral Aneurysm: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• Figure 16. North America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
• Figure 17. North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 18. North America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
• Figure 19. Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 20. Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 21. Europe Peripheral Liquid Embolic Agents Market by Key Countries, 2023
• Figure 22. Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 23. Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
• Figure 24. Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 25. United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 26. France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 27. Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 28. Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 29. Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 30. Asia Pacific Peripheral Liquid Embolic Agents Market by Key Countries, 2023
• Figure 31. Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 32. Asia Pacific: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
• Figure 33. China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 34. Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 35. India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 36. Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 37. South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 38. Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 39. Middle East & Africa Peripheral Liquid Embolic Agents Market by Key Countries, 2023
• Figure 40. Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 41. Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
• Figure 42. Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 43. South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 44. United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 45. Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 46. South & Central America Peripheral Liquid Embolic Agents Market by Key Countries, 2023
• Figure 47. South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 48. South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Key Countries, 2023 and 2031 (%)
• Figure 49. Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 50. Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 51. Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031(US$ Thousand)
• Figure 52. Growth Strategies in the Peripheral Liquid Embolic Agents Market

The peripheral liquid embolic agents market is expected to grow from US$ 40.42 million in 2023 to US$ 81.41 million by 2031; it is anticipated to record a CAGR of 9.1% from 2023 to 2031.

Peripheral liquid embolic agents are substances used in interventional radiology procedures to block leaking blood vessel and malformations. These agents solidify after injecting which forms plug and block the blood flow to the targeted area.

Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents Acts as a Trend for Market Growth

Liquid embolism is a topic of great interest in bioengineering, particularly in peripheral procedures. Liquid embolic agents can penetrate peripheral, nidus, or distal areas where coils or catheters cannot reach. Although currently used liquid embolic agents can meet most clinical needs, they have some shortcomings. Therefore, various novel liquid embolic agents have been developed to improve imaging characteristics, reduce complications, optimize flow performance, and achieve drug loading capability. The systematic investigation of additional important material characteristics such as associated side effects (e.g., toxicity and adhesion), biofunctional (biocompatibility, biodegradability, biomechanics, and bioactivity), and radiopacity is essential for the development of clinically tailored embolic agents in the field of minimally invasive imaging procedures.

Temperature-sensitive polymer solutions can change from a sol-injectable state to a gel state at room temperature in the body. Poly(N-isopropyl acrylamide) (PNIPAAm) exhibits a reversible phase transition in response to a lower critical solution temperature (LCST) of 32 °C. According to a study published in the Journal of Controlled Release by Qian et al. in 2015, poly(N-isopropylacrylamide-co-butylmethyl acrylate) gels with iohexol dispersions for TACE of liver cancer demonstrated effective embolization of renal arteries in rabbits and sustained release of doxorubicin. Similarly, as per a study published in the National Library of Medicine by Wang et al. in 2011, chitosan/B-glycerophosphate (C/GP) successfully closed renal arteries in rabbits, indicating to be a potential embolization agent. Likewise, Zhao et al. also investigated temperature-sensitive PNIPAAm-iohexol nano gels for embolization, according to a research study published Wiley Online Library in 2011. The hydrophobic interactions above the phase transition temperature (36.5 °C) lead to a hierarchical 3D gel network for in situ vessel casting. Compared to Lipiodol, a peripheral embolic agent, the nanogel provided better peripheral embolization in VX2 liver tumors in rabbits.

Furthermore, a poloxamer 407 (a triblock copolymer of polyethylene oxide a-polypropylene oxide b-polyethylene oxide a) containing a thermosensitive liquid embolic hydrogel has been proposed for liver cancer therapy. This composite hydrogel composed of poloxamer 407, hydroxymethyl cellulose, sodium alginate, and iodixanol (PSHI) presented two phases with increasing temperature: a flowing sol and a shrunken gel. Notably, complete occlusion of the VX2 liver cancer model was demonstrated with PSHI-Ca2+ as the tumor disappeared after embolization.

pH-sensitive active ingredients undergo a phase transition due to the pH change between the in vitro and physiological environments. These hydrogels swell and collapse in response to pH, which is used to control drug release.

As per a study published in the Royal Society of Chemistry by Nguyen et al. in 2016, PCLA-PUSSM, a copolymer consisting of poly(ε-caprolactone-co-lactide) (PCLA), PEG, and poly(urethane sulfide sulfamethazine) (PUSSM) was developed, for TACE of HCC. This biodegradable material was loaded with doxorubicin and exhibited a phase transition in response to decreasing pH. The hydrogel successfully embolized a liver tumor from a VX2 rabbit tumor model while providing a sustained release of doxorubicin. In a rat model, embolization stopped blood supply to the tumor, creating an acidic environment through hypoxia and inducing lactic acidosis. The low pH triggered drug release and successfully inhibited tumor growth in vivo.

Some of the liquid embolic agents under trial for temperature-sensitive and pH-triggered are given below:

• Table 1. Liquid Embolic Agents Under Trial for Temperature-Sensitive and pH-Triggered Gelation

Liquid Embolic Agents Mechanism Advantage Classical Usage Scenarios or Trial Conditions

Chitosan/B- glycerophosphate (chitosan/B-GP) Temperature- and pH-triggered gelation Drug delivery Renal arteries in rabbits

Silk-Elastin-Like proteins (SELPs) Temperature- triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel (PIB nanogel) Temperature- triggered gelation A better embolization than lipiodol Primary VX2 liver tumors in rabbit

Poloxamer 407 Temperature- triggered gelation Temporary vascular occlusion Renal arteries in canines

poloxamer 407, sodium alginate, hydroxymethyl cellulose, iodixanol, and calcium ions (PSHI-Ca2+) Temperature- triggered gelation Radiopacity Primary VX2 liver tumors in rabbit

Sulfamethazine-based hydrogel pH-triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Poly(Amino Ester Urethane) block polymer (PEAU) Temperature- and pH-triggered gelation Drug delivery Primary VX2 liver tumors in rabbit

Thus, the growing focus and developments on temperature-induced phase change systems and pH-triggered embolic agents are expected to bring new trends in the peripheral liquid embolic agents market in the coming years.

The peripheral liquid embolic agents market analysis has been carried out by considering the following segments: type, application and geography. Based on type, the peripheral liquid embolic agents market is bifurcated into polymerizing liquid embolic agents and precipitating liquid embolic agents. In terms of application, the peripheral liquid embolic agents market is classified into endoleak type II, malformations, bleedings and trauma, varicose vein, tumors, and visceral aneurysm..

The scope of the peripheral liquid embolic agents market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the biggest contributor to the global peripheral liquid embolic agents market. Asia Pacific is predicted to show the highest CAGR in the market during 2023-2031.

The North America regional market growth is attributed to the increasing cases of aneurysms, trauma, and others across the region. The market in Canada is anticipated to grow because of rising government support for addressing the increasing concerns regarding peripheral disorders. The market in Mexico is estimated to grow owing to the growing pharma industries and medical tourism. The Asia Pacific peripheral liquid embolic agents market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in the region is driven by various factors such as the rising prevalence of peripheral artery diseases (PAD), increasing demand for minimally invasive procedures, growing number of hospitals and ambulatory surgery centers, rising focus on developing countries by market players , and developing healthcare infrastructure in Asia Pacific

Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA), The Pan American Health Organization (PAHO), and World Health Organization (WHO) are a few key primary and secondary sources referred to while preparing the report on the peripheral liquid embolic agents market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Peripheral Liquid Embolic Agents Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
• 4.3 Regional Pricing Analysis, 2023

5. Peripheral Liquid Embolic Agents Market - Key Market Dynamics

• 5.1 Peripheral Liquid Embolic Agents Market - Key Market Dynamics
• 5.2 Market Drivers
  • 5.2.1 Rising Incidence of Peripheral Vascular Diseases
  • 5.2.2 Increasing Demand for Minimally Invasive Procedures
• 5.3 Market Restraints
  • 5.3.1 High Cost of Embolization Agents
• 5.4 Market Opportunities
  • 5.4.1 Growing Strategic Initiatives by Market Players
• 5.5 Future Trends
  • 5.5.1 Developments in Temperature-Induced Phase Change Systems and pH-Triggered Embolic Agents
• 5.6 Impact analysis

6. Peripheral Liquid Embolic Agents Market - Global Market Analysis

• 6.1 Peripheral Liquid Embolic Agents Market Revenue (US$ Thousand), 2021-2031
• 6.2 Peripheral Liquid Embolic Agents Market Analysis
• 6.3 Market Positioning Analysis, 2023

7. Peripheral Liquid Embolic Agents Market Analysis - by Type

• 7.1 Polymerizing Liquid Embolic Agent
  • 7.1.1 Overview
  • 7.1.2 Polymerizing Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• 7.2 Precipitating Liquid Embolic Agent
  • 7.2.1 Overview
  • 7.2.2 Precipitating Liquid Embolic Agent: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Peripheral Liquid Embolic Agents Market Analysis - by Application

• 8.1 Endoleak Type II
  • 8.1.1 Overview
  • 8.1.2 Endoleak Type II: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• 8.2 Malformations
  • 8.2.1 Overview
  • 8.2.2 Malformations: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• 8.3 Bleedings and Trauma
  • 8.3.1 Overview
  • 8.3.2 Bleedings and Trauma: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• 8.4 Varicose Vein
  • 8.4.1 Overview
  • 8.4.2 Varicose Vein: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• 8.5 Tumours
  • 8.5.1 Overview
  • 8.5.2 Tumours: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
• 8.6 Visceral Aneurysm
  • 8.6.1 Overview
  • 8.6.2 Visceral Aneurysm: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Peripheral Liquid Embolic Agents Market - Geographical Analysis

• 9.1 North America
  • 9.1.1 North America Peripheral Liquid Embolic Agents Market Overview
  • 9.1.2 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
    • 9.1.2.1 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
    • 9.1.2.2 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
      • 9.1.2.2.1 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.1.2.2.2 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.1.2.2.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.1.2.2.4 North America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
    • 9.1.2.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
  • 9.1.3 North America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
    • 9.1.3.1 Canada: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.1.3.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.1.3.1.1.1 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.1.3.1.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.1.3.1.2 Canada: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.1.3.2 Mexico: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.1.3.2.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.1.3.2.1.1 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.1.3.2.1.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.1.3.2.2 Mexico: Peripheral Liquid Embolic Agents Market Breakdown, by Application
• 9.2 Europe
  • 9.2.1 Europe Peripheral Liquid Embolic Agents Market Overview
  • 9.2.2 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
    • 9.2.2.1 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
    • 9.2.2.2 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
      • 9.2.2.2.1 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.2.2.2.2 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.2.2.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.2.2.2.4 Europe: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
    • 9.2.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
  • 9.2.3 Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
    • 9.2.3.1 Germany: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.3.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.2.3.1.1.1 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.2.3.1.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.2.3.1.2 Germany: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.2.3.2 United Kingdom: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.3.2.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.2.3.2.1.1 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.2.3.2.1.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.2.3.2.2 United Kingdom: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.2.3.3 France: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.3.3.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.2.3.3.1.1 France: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.2.3.3.1.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.2.3.3.2 France: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.2.3.4 Italy: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.3.4.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.2.3.4.1.1 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.2.3.4.1.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.2.3.4.2 Italy: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.2.3.5 Spain: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.3.5.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.2.3.5.1.1 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.2.3.5.1.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.2.3.5.2 Spain: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.2.3.6 Rest of Europe: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.3.6.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.2.3.6.1.1 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.2.3.6.1.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.2.3.6.2 Rest of Europe: Peripheral Liquid Embolic Agents Market Breakdown, by Application
• 9.3 Asia Pacific
  • 9.3.1 Asia Pacific Peripheral Liquid Embolic Agents Market Overview
  • 9.3.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
    • 9.3.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
    • 9.3.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
      • 9.3.2.2.1 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.3.2.2.2 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.3.2.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.3.2.2.4 Asia Pacific: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
    • 9.3.2.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
  • 9.3.3 Asia Pacific: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
    • 9.3.3.1 China: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.3.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.3.3.1.1.1 China: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.3.3.1.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.3.3.1.2 China: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.3.3.2 Japan: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.3.2.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.3.3.2.1.1 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.3.3.2.1.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.3.3.2.2 Japan: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.3.3.3 India: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.3.3.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.3.3.3.1.1 India: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.3.3.3.1.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.3.3.3.2 India: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.3.3.4 Australia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.3.4.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.3.3.4.1.1 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.3.3.4.1.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.3.3.4.2 Australia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.3.3.5 South Korea: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.3.5.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.3.3.5.1.1 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.3.3.5.1.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.3.3.5.2 South Korea: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.3.3.6 Rest of APAC: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.3.6.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.3.3.6.1.1 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.3.3.6.1.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.3.3.6.2 Rest of APAC: Peripheral Liquid Embolic Agents Market Breakdown, by Application
• 9.4 Middle East & Africa
  • 9.4.1 Middle East & Africa Peripheral Liquid Embolic Agents Market Overview
  • 9.4.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
    • 9.4.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
    • 9.4.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
      • 9.4.2.2.1 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.4.2.2.2 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.4.2.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.4.2.2.4 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
    • 9.4.2.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
  • 9.4.3 Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
    • 9.4.3.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.3.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.4.3.1.1.1 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.4.3.1.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.4.3.1.2 Saudi Arabia: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.4.3.2 South Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.3.2.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.4.3.2.1.1 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.4.3.2.1.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.4.3.2.2 South Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.4.3.3 United Arab Emirates: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.3.3.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.4.3.3.1.1 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.4.3.3.1.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.4.3.3.2 United Arab Emirates: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.4.3.4 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.3.4.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.4.3.4.1.1 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.4.3.4.1.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.4.3.4.2 Rest of Middle East & Africa: Peripheral Liquid Embolic Agents Market Breakdown, by Application
• 9.5 South and Central America
  • 9.5.1 South and Central America Peripheral Liquid Embolic Agents Market Overview
  • 9.5.2 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
    • 9.5.2.1 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Type
    • 9.5.2.2 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Type
      • 9.5.2.2.1 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.5.2.2.2 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Polymerizing Liquid Embolic Agent
      • 9.5.2.2.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Precipitating Liquid Embolic Agent
      • 9.5.2.2.4 South and Central America: Peripheral Liquid Embolic Agents Market - Volume and Forecast Analysis - by Precipitating Liquid Embolic Agent
    • 9.5.2.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Application
  • 9.5.3 South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast Analysis - by Country
    • 9.5.3.1 Brazil: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.5.3.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.5.3.1.1.1 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.5.3.1.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.5.3.1.2 Brazil: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.5.3.2 Argentina: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.5.3.2.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.5.3.2.1.1 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.5.3.2.1.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.5.3.2.2 Argentina: Peripheral Liquid Embolic Agents Market Breakdown, by Application
    • 9.5.3.3 Rest of South and Central America: Peripheral Liquid Embolic Agents Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.5.3.3.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Type
      • 9.5.3.3.1.1 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Polymerizing Liquid Embolic Agent
      • 9.5.3.3.1.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Precipitating Liquid Embolic Agent
      • 9.5.3.3.2 Rest of South and Central America: Peripheral Liquid Embolic Agents Market Breakdown, by Application

10. Industry Landscape

• 10.1 Overview
• 10.2 Growth Strategies in the Peripheral Liquid Embolic Agents Market
• 10.3 Inorganic Growth Strategies
  • 10.3.1 Overview
• 10.4 Organic Growth Strategies
  • 10.4.1 Overview

11. Company Profiles

• 11.1 Medtronic Plc
  • 11.1.1 Key Facts
  • 11.1.2 Business Description
  • 11.1.3 Products and Services
  • 11.1.4 Financial Overview
  • 11.1.5 SWOT Analysis
  • 11.1.6 Key Developments
• 11.2 B Braun SE
  • 11.2.1 Key Facts
  • 11.2.2 Business Description
  • 11.2.3 Products and Services
  • 11.2.4 Financial Overview
  • 11.2.5 SWOT Analysis
  • 11.2.6 Key Developments
• 11.3 Guerbet SA
  • 11.3.1 Key Facts
  • 11.3.2 Business Description
  • 11.3.3 Products and Services
  • 11.3.4 Financial Overview
  • 11.3.5 SWOT Analysis
  • 11.3.6 Key Developments
• 11.4 Sirtex Medical Ltd
  • 11.4.1 Key Facts
  • 11.4.2 Business Description
  • 11.4.3 Products and Services
  • 11.4.4 Financial Overview
  • 11.4.5 SWOT Analysis
  • 11.4.6 Key Developments
• 11.5 Balt
  • 11.5.1 Key Facts
  • 11.5.2 Business Description
  • 11.5.3 Products and Services
  • 11.5.4 Financial Overview
  • 11.5.5 SWOT Analysis
  • 11.5.6 Key Developments
• 11.6 MicroVention Inc
  • 11.6.1 Key Facts
  • 11.6.2 Business Description
  • 11.6.3 Products and Services
  • 11.6.4 Financial Overview
  • 11.6.5 SWOT Analysis
  • 11.6.6 Key Developments
• 11.7 Johnson & Johnson
  • 11.7.1 Key Facts
  • 11.7.2 Business Description
  • 11.7.3 Products and Services
  • 11.7.4 Financial Overview
  • 11.7.5 SWOT Analysis
  • 11.7.6 Key Developments
• 11.8 GEM srl
  • 11.8.1 Key Facts
  • 11.8.2 Business Description
  • 11.8.3 Products and Services
  • 11.8.4 Financial Overview
  • 11.8.5 SWOT Analysis
  • 11.8.6 Key Developments

12. Appendix

• 12.1 About The Insight Partners
• 12.2 Glossary of Terms